Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology

We developed a rapid single nucleotide polymorphism (SNP) detection system named smart amplification process version 2 (SMAP 2). Because DNA amplification only occurred with a perfect primer match, amplification alone was sufficient to identify the target allele. To achieve the requisite fidelity to support this claim, we used two new and complementary approaches to suppress exponential background DNA amplification that resulted from mispriming events. SMAP 2 is isothermal and achieved SNP detection from whole human blood in 30 min when performed with a new DNA polymerase that was cloned and isolated from Alicyclobacillus acidocaldarius (Aac pol). Furthermore, to assist the scientific community in configuring SMAP 2 assays, we developed software specific for SMAP 2 primer design. With these new tools, a high-precision and rapid DNA amplification technology becomes available to aid in pharmacogenomic research and molecular-diagnostics applications.

[1]  Tim Hubbard.  Finishing the euchromatic sequence of the human genome , 2004 .

[2]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[3]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[4]  P. Hsieh,et al.  Identification and Characterization of a Thermostable MutS Homolog from Thermus aquaticus(*) , 1996, The Journal of Biological Chemistry.

[5]  Sha-Sha Wang,et al.  Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system. , 2003, Clinical chemistry.

[6]  K. Gunderson,et al.  High-throughput SNP genotyping on universal bead arrays. , 2005, Mutation research.

[7]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[8]  T. Muramatsu,et al.  Investigation of genetic risk factors associated with alcoholism. , 1996, Alcoholism, clinical and experimental research.

[9]  Bruce P. Neri,et al.  Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes , 1999, Nature Biotechnology.

[10]  S. Harada,et al.  New strategy for detection of ALDH2 mutant. , 1993, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[11]  Phyllida Roe,et al.  Integration of DNA ligation and rolling circle amplification for the homogeneous, end-point detection of single nucleotide polymorphisms. , 2002, Nucleic acids research.

[12]  A. Shuldiner,et al.  Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. , 2002, Diabetes.

[13]  G R Wilkinson,et al.  The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. , 1994, The Journal of biological chemistry.

[14]  A. B. Perkins,et al.  High-density single-nucleotide polymorphism maps of the human genome. , 2005, Genomics.

[15]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[16]  C. Bogardus,et al.  Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. , 1995, The New England journal of medicine.

[17]  P. Leissner,et al.  DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysis. , 2004, BioTechniques.

[18]  Ronald W. Davis,et al.  Multiplexed genotyping with sequence-tagged molecular inversion probes , 2003, Nature Biotechnology.

[19]  S. P. Fodor,et al.  Large-scale genotyping of complex DNA , 2003, Nature Biotechnology.

[20]  International Human Genome Sequencing Consortium.  Finishing the euchromatic sequence of the human genome , 2004 .

[21]  T. Notomi,et al.  Validation of the Loop-Mediated Isothermal Amplification Method for Single Nucleotide Polymorphism Genotyping with Whole Blood , 2003 .